MiCo BioMed Past Earnings Performance
Past criteria checks 0/6
MiCo BioMed's earnings have been declining at an average annual rate of -49.8%, while the Medical Equipment industry saw earnings growing at 11.2% annually. Revenues have been declining at an average rate of 66.6% per year.
Key information
-49.8%
Earnings growth rate
-41.4%
EPS growth rate
| Medical Equipment Industry Growth | 22.7% |
| Revenue growth rate | -66.6% |
| Return on equity | -71.0% |
| Net Margin | -480.2% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
No updates
Revenue & Expenses BreakdownBeta
How MiCo BioMed makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 5,367 | -25,774 | 7,852 | 4,036 |
| 30 Sep 23 | 5,145 | -33,168 | 8,064 | 4,726 |
| 30 Jun 23 | 5,691 | -34,801 | 10,870 | 5,630 |
| 31 Mar 23 | 8,261 | -39,764 | 14,908 | 6,389 |
| 31 Dec 22 | 16,111 | -38,893 | 16,560 | 7,454 |
| 30 Sep 22 | 21,617 | -26,305 | 18,015 | 7,597 |
| 30 Jun 22 | 26,477 | -22,378 | 17,798 | 7,970 |
| 31 Mar 22 | 27,117 | -16,269 | 16,781 | 8,133 |
| 31 Dec 21 | 30,302 | -10,575 | 16,667 | 7,831 |
| 30 Sep 21 | 35,736 | 2,899 | 15,951 | 7,526 |
| 30 Jun 21 | 41,106 | 7,358 | 14,024 | 7,142 |
| 31 Mar 21 | 56,823 | -961 | 12,580 | 6,564 |
| 31 Dec 20 | 45,672 | -5,776 | 10,411 | 6,150 |
| 31 Dec 19 | 4,098 | -14,632 | 5,140 | 5,114 |
Quality Earnings: A214610 is currently unprofitable.
Growing Profit Margin: A214610 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A214610 is unprofitable, and losses have increased over the past 5 years at a rate of 49.8% per year.
Accelerating Growth: Unable to compare A214610's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A214610 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (8.8%).
Return on Equity
High ROE: A214610 has a negative Return on Equity (-71%), as it is currently unprofitable.